#ASH25: New data from Gilead, J&J set up a bispecific, CAR-T rivalrynews2025-12-09T19:17:45+00:00December 9th, 2025|Endpoints News|
J&J-backed Cellular Origins raises $40M for cell therapy manufacturing news2025-12-09T17:53:07+00:00December 9th, 2025|Endpoints News|
SanegeneBio raises $110M in follow-up to metabolic deal with Lillynews2025-12-09T16:43:39+00:00December 9th, 2025|Endpoints News|
Novartis to partner with AI-focused Relation on atopic diseasesnews2025-12-09T16:19:37+00:00December 9th, 2025|Endpoints News|
Notes from the 2025 SABEW med tech fellowshipnews2025-12-09T16:12:44+00:00December 9th, 2025|Endpoints News|
#ASH25: Early in vivo CAR-T results like Kelonia’s elicit excitement across the fieldnews2025-12-09T16:04:26+00:00December 9th, 2025|Endpoints News|
EpilepsyGTx gets $33M to test epilepsy gene therapy in Phase 1/2anews2025-12-09T16:00:08+00:00December 9th, 2025|Endpoints News|
Stealthy biotech Sidera Bio raises $109M; Assembly’s data for oral herpes drugsnews2025-12-09T15:54:43+00:00December 9th, 2025|Endpoints News|
Seven biotechs eye $2.3B in public offerings after data readoutsnews2025-12-09T15:43:26+00:00December 9th, 2025|Endpoints News|
Radial raises $50M to treat mental health in non-traditional waysnews2025-12-09T14:00:05+00:00December 9th, 2025|Endpoints News|
